Sichuan Deebio Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Sichuan Deebiotech Corp., Ltd. and was honored as a national high-tech enterprise. Relying on the abundant domestic biological API resources, Deebio focuses on the extraction of biological API and uses a unique 3H Technology (full-process enzyme activity protection technology) to produce the bio-enzyme products with high activity, high purity and high stability. ?
Deebio Pharmaceutical mainly produces pancreatic kininogenase, pepsin, gastrin, elastase, heparin sodium, cytochrome C, chondroitin sulfate sodium, trypsin chymotrypsin, chymotrypsin, trypsin, heme, bovine liver extract, thyroid, ursodeoxycholic acid, type II collagen and other products. Our products are exported to Europe, the United States, South America, India, Russia, South Korea, Japan and other countries and regions, occupying an important position in the global bio-enzyme API market.
Deebio Pharmaceutical, which is developing, aims to be the world's advanced biological API company, and aim to serve human health, let the world witness the power of China's bio-enzyme manufacturing.